{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:04:47Z","timestamp":1784696687715,"version":"3.55.0"},"reference-count":33,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Shenzhen Science and Technology Program","award":["JCYJ20250604150048016"],"award-info":[{"award-number":["JCYJ20250604150048016"]}]},{"name":"Shenzhen Science and Technology Program","award":["JCYJ20240813152313019"],"award-info":[{"award-number":["JCYJ20240813152313019"]}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82374531"],"award-info":[{"award-number":["82374531"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Apoptosis signal-regulating kinase 1 (ASK1) represents a critical therapeutic target for metabolic dysfunction-associated steatohepatitis (MASH). Natural products, owing to their unique chemical diversity, constitute a rich reservoir for discovering novel ASK1 inhibitors. The emergence of artificial intelligence-assisted drug discovery (AIDD) has opened new avenues for exploring small-molecule inhibitors. Through virtual screening, molecular docking, interaction profiling, molecular dynamics simulations, and MM-GBSA binding free energy calculations, we systematically evaluated the binding mode, stability, and key residue contributions of the CMNPD10921\u2013ASK1 complex. CMNPD10921 stably occupied the ASK1 active pocket, forming hydrophobic interactions and hydrogen bonds with multiple key amino acid residues. MM-GBSA analysis yielded a total computed binding free energy of \u221231.15 kcal\/mol, suggesting a computationally favorable interaction, with van der Waals forces serving as the dominant energetic driver of complex stabilization. Residue energy decomposition further identified ILE324, THR288, and THR639 as major contributors to ligand binding. Integrating deep learning, molecular simulation, and quantum chemical calculations, this study successfully identified CMNPD10921 from a vast natural product library as a putative lead compound candidate targeting the ASK1 central regulatory region, offering a novel candidate molecule for anti-MASH drug development.<\/jats:p>","DOI":"10.3390\/ijms27146438","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:00:17Z","timestamp":1784548817000},"page":"6438","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Deep Learning-Based Virtual Screening Identifies Potential Small-Molecule Inhibitors of ASK1: Natural Product Lead Discovery for MASH"],"prefix":"10.3390","volume":"27","author":[{"given":"Ruiqi","family":"Zhao","sequence":"first","affiliation":[{"name":"The Fourth Clinical Medical College, Guangzhou University of Chinese Medicine, Shenzhen 518033, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahua","family":"Yang","sequence":"additional","affiliation":[{"name":"The Fourth Clinical Medical College, Guangzhou University of Chinese Medicine, Shenzhen 518033, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Han","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou 510006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Tang","sequence":"additional","affiliation":[{"name":"The Fourth Clinical Medical College, Guangzhou University of Chinese Medicine, Shenzhen 518033, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Hu","sequence":"additional","affiliation":[{"name":"The Fourth Clinical Medical College, Guangzhou University of Chinese Medicine, Shenzhen 518033, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiesheng","family":"Guo","sequence":"additional","affiliation":[{"name":"The Fourth Clinical Medical College, Guangzhou University of Chinese Medicine, Shenzhen 518033, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqing","family":"Ma","sequence":"additional","affiliation":[{"name":"Faculty of Chinese Medicine, Macau University of Science and Technology, Taipa, Macao 999078, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialing","family":"Sun","sequence":"additional","affiliation":[{"name":"The Fourth Clinical Medical College, Guangzhou University of Chinese Medicine, Shenzhen 518033, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4758-0060","authenticated-orcid":false,"given":"Xiaozhou","family":"Zhou","sequence":"additional","affiliation":[{"name":"The Fourth Clinical Medical College, Guangzhou University of Chinese Medicine, Shenzhen 518033, China"},{"name":"Faculty of Chinese Medicine, Macau University of Science and Technology, Taipa, Macao 999078, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A Multisociety Delphi Consensus Statement on New Fatty Liver Disease Nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_2","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), and European Association for the Study of Obesity (EASO) (2024). EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). J. Hepatol., 81, 492\u2013542."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The Global Epidemiology of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH): A Systematic Review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S2468-1253(22)00317-X","article-title":"Global Prevalence of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis in the Overweight and Obese Population: A Systematic Review and Meta-Analysis","volume":"8","author":"Quek","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","article-title":"A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2036205","article-title":"A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH","volume":"385","author":"Francque","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa2401943","article-title":"Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis","volume":"391","author":"Loomba","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD Development and Therapeutic Strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jhep.2020.02.027","article-title":"Selonsertib for Patients with Bridging Fibrosis or Compensated Cirrhosis Due to NASH: Results from Randomized Phase III STELLAR Trials","volume":"73","author":"Harrison","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e123294","DOI":"10.1172\/jci.insight.123294","article-title":"ASK1 Inhibition Reduces Cell Death and Hepatic Fibrosis in an Nlrp3 Mutant Liver Injury Model","volume":"5","author":"Geisler","year":"2020","journal-title":"JCI Insight"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/hep.31801","article-title":"TNF-\u03b1-Induce Protein 8-like 1 Inhibits Hepatic Steatosis, Inflammation, and Fibrosis by Suppressing Polyubiquitination of Apoptosis Signal-Regulating Kinase 1","volume":"74","author":"Wu","year":"2021","journal-title":"Hepatology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/embo-reports\/kve046","article-title":"ASK1 Is Required for Sustained Activations of JNK\/P38 MAP Kinases and Apoptosis","volume":"2","author":"Tobiume","year":"2001","journal-title":"EMBO Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3892\/mmr.2023.12934","article-title":"ASK1 Inhibitor NQDI-1 Decreases Oxidative Stress and Neuroapoptosis via the ASK1\/P38 and JNK Signaling Pathway in Early Brain Injury after Subarachnoid Hemorrhage in Rats","volume":"27","author":"Duan","year":"2023","journal-title":"Mol. Med. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1111\/cas.12024","article-title":"Apoptosis Signal-Regulating Kinase-1 Inhibitor as a Potent Therapeutic Drug for the Treatment of Gastric Cancer","volume":"103","author":"Hayakawa","year":"2012","journal-title":"Cancer Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural Products in Drug Discovery: Advances and Opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural Products as Sources of New Drugs over the Nearly Four Decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J. Nat. Prod."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1039\/D3NP00061C","article-title":"Marine Natural Products","volume":"41","author":"Carroll","year":"2024","journal-title":"Nat. Prod. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13321-020-00478-9","article-title":"COCONUT Online: Collection of Open Natural Products Database","volume":"13","author":"Sorokina","year":"2021","journal-title":"J. Cheminform."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"D509","DOI":"10.1093\/nar\/gkaa763","article-title":"CMNPD: A Comprehensive Marine Natural Products Database towards Facilitating Drug Discovery from the Ocean","volume":"49","author":"Lyu","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41586-023-05905-z","article-title":"Computational Approaches Streamlining Drug Discovery","volume":"616","author":"Sadybekov","year":"2023","journal-title":"Nature"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev-biodatasci-020222-025013","article-title":"Recent Developments in Ultralarge and Structure-Based Virtual Screening Approaches","volume":"6","author":"Gorgulla","year":"2023","journal-title":"Annu. Rev. Biomed. Data Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/jgh.16087","article-title":"Mechanism of ASK1 Involvement in Liver Diseases and Related Potential Therapeutic Targets: A Critical Pathway Molecule Worth Investigating","volume":"38","author":"Chen","year":"2023","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4062\/biomolther.2020.016","article-title":"Selonsertib Inhibits Liver Fibrosis via Downregulation of ASK1\/MAPK Pathway of Hepatic Stellate Cells","volume":"28","author":"Yoon","year":"2020","journal-title":"Biomol. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"102043","DOI":"10.1016\/j.redox.2021.102043","article-title":"Proteasome Dysfunction Under Compromised Redox Metabolism Dictates Liver Injury in NASH through ASK1\/PPAR\u03b3 Binodal Complementary Modules","volume":"45","author":"Das","year":"2021","journal-title":"Redox Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e10124","DOI":"10.15252\/emmm.201810124","article-title":"Liver ASK1 Protects from Non-Alcoholic Fatty Liver Disease and Fibrosis","volume":"11","author":"Challa","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: A New Tool to Perform End-State Free Energy Calculations with GROMACS","volume":"17","author":"Valiente","year":"2021","journal-title":"J. Chem. Theory Comput."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1080\/17460441.2021.1942836","article-title":"What Is the Current Value of MM\/PBSA and MM\/GBSA Methods in Drug Discovery?","volume":"16","author":"Tuccinardi","year":"2021","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"W531","DOI":"10.1093\/nar\/gkab294","article-title":"PLIP 2021: Expanding the Scope of the Protein-Ligand Interaction Profiler to DNA and RNA","volume":"49","author":"Adasme","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"ref_31","first-page":"102950","article-title":"UniSite: The First Cross-Structure Dataset and Learning Framework for End-to-End Ligand Binding Site Detection","volume":"38","author":"Fan","year":"2026","journal-title":"Adv. Neural Inf. Process. Syst."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/jcc.22885","article-title":"Multiwfn: A Multifunctional Wavefunction Analyzer","volume":"33","author":"Lu","year":"2012","journal-title":"J. Comput. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"82503","DOI":"10.1063\/5.0216272","article-title":"A Comprehensive Electron Wavefunction Analysis Toolbox for Chemists, Multiwfn","volume":"161","author":"Lu","year":"2024","journal-title":"J. Chem. Phys."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/14\/6438\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:28:56Z","timestamp":1784694536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/14\/6438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":33,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["ijms27146438"],"URL":"https:\/\/doi.org\/10.3390\/ijms27146438","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]}}}